Surbhi Shah, MD
Hematology & Oncology · Scottsdale, AZNPI 1649400680
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,924 of the $24,496 with a category attached, or 93.6%. Sanofi accounts for 71.0% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $17,655, 4.2 times the $4,231 reported in 2023.
Across 10 payments — averaging $2449.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$17K
- Argenx US, Inc.$4K
- Sobi, Inc$3K
- CSL Behring$117
Across 3 payments — averaging $9434.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$28K
- Argenx US, Inc.$159
What the payments were for
- Consulting fees$22,92494%
- Travel & lodging$1,0984%
- Food & beverage$4742%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 7 | $17,404 |
| Argenx US, Inc. | 1 | $4,200 |
| Sobi, Inc | 1 | $2,775 |
| CSL Behring | 1 | $117 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,496 in reported general payments places this provider in the 75th percentile of 261 hematology & oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Warfarin Sodium | 11 | $133 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Scottsdale
- Jeffrey SchriberScottsdale$715K
- Tanios Bekaii-SaabScottsdale$527K
- Rajesh KukunoorScottsdale$499K
- Yousef ZakhariaScottsdale$214K
- Thai HoScottsdale$190K
- Alan BryceScottsdale$157K
- Daniel AhnScottsdale$91K
- Brendan CurleyScottsdale$87K
- Alexander StewartScottsdale$76K
- Saurabh ChhabraScottsdale$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.